Amyotrophic Lateral Sclerosis Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Amyotrophic Lateral Sclerosis Market Trends and the market is Segmented by Treatment Type (Medication and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Amyotrophic Lateral Sclerosis Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Amyotrophic Lateral Sclerosis (ALS) Treatment Industry Overview

The amyotrophic lateral sclerosis treatment market is slightly fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known. Some companies are Mitsubishi Tanabe Pharma Corporation, Sun Pharmaceutical Industries Ltd., CORESTEM, Inc, BrainStorm Cell Limited, Amylyx Pharmaceuticals Inc., AB Science, Ionis Pharmaceuticals, Biohaven Pharmaceutical, Biogen, and F.Hoffmann-La Roche AG.

Amyotrophic Lateral Sclerosis (ALS) Treatment Market Leaders

  1. Mitsubishi Tanabe Pharma Corporation

  2. CORESTEM, Inc

  3. BrainStorm Cell Limited

  4. Amylyx Pharmaceuticals Inc.

  5. Biogen

  6. *Disclaimer: Major Players sorted in no particular order
Amyotrophic Lateral Sclerosis Treatment Market Concentration

Amyotrophic Lateral Sclerosis Treatment Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?